Skip to main content
APM logo

Aptorum Group Limited

APMNASDAQHealthcareBiotechnology

$8.41Today:- (-)1Y +442.58%

As of Jul 27, 2026 close

Market cap
$61.83M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.60$12.24
Volume (live)
-
Avg. volume (3M)
34.54K

Aptorum Group (APM) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Aptorum Group used $1.84M of cash in operating activities. Free cash flow was −$1.84M.

Aptorum Group Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Aptorum Group Limited (APM) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-1.38-4.27-4.34-11.53-27.117.07-20.12-15.13-2.55
Depreciation & Amortization0.000.261.381.561.191.261.300.680.06
Deferred Income Tax0.000.000.000.007.96-24.46-1.530.000.00
Stock Based Compensation0.000.001.271.651.681.481.610.000.00
Change in Working Capital-0.10-0.210.461.401.020.051.22-0.39-0.20
Change in Accounts Receivable0.020.040.13-0.10-0.02-0.02-0.040.00-0.05
Change in Inventory0.000.000.010.010.000.000.00-0.030.00
Change in Accounts Payable-0.030.000.401.920.590.800.990.060.00
Change in Other Working Capital0.18-0.25-0.08-0.430.61-0.730.27-0.41-0.15
Other Operating Activities0.183.03-6.49-5.400.61-1.204.144.81-2.93
Net Cash from Operating Activities-1.84-1.19-7.72-12.32-14.65-15.93-13.38-10.04-5.78
Investing Activities
Capital Expenditures0.000.000.00-0.19-0.14-0.16-1.11-6.06-3.06
Acquisitions0.000.060.020.00-0.1125.240.270.420.00
Purchases of Investments0.000.000.090.13-0.010.95-0.20-0.500.00
Sales/Maturities of Investments0.000.000.090.0020.120.951.000.0016.05
Other Investing Activities0.000.000.522.63-3.351.05-0.070.08-0.19
Net Cash from Investing Activities0.000.060.622.4416.511.84-0.11-6.0612.80
Financing Activities
Debt Repayment0.000.00-3.00-0.05-5.54-5.36-7.3216.060.48
Common Stock Issued5.070.001.590.174.0017.500.0011.058.60
Dividends Paid0.000.000.000.000.00-0.760.000.000.00
Other Financing Activities-0.650.00-0.040.010.82-0.720.00-1.640.00
Net Cash from Financing Activities4.420.004.096.632.7812.42-7.3225.489.08
Summary
Net Change in Cash2.58-1.13-3.01-3.254.64-1.67-20.819.3816.10
Cash at Beginning of Period0.872.015.018.263.635.2926.1116.730.62
Cash at End of Period3.450.872.015.018.263.635.2926.1116.73
Free Cash Flow-1.84-1.19-7.73-12.51-14.79-16.09-14.49-16.10-8.84
Supplemental Disclosures
Interest Paid--0.090.060.270.13---

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Aptorum Group Cash Flow

What is Aptorum Group's free cash flow?

Aptorum Group had negative free cash flow of $1.84M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Aptorum Group pay dividends or buy back shares?

Aptorum Group's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition